Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2) (N-Term) Peptide

EIF4G2 Reactivité: Souris Hôte: Synthetic BP
N° du produit ABIN8099966
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2) (N-Term) Peptide (ABIN8099966)

Antigène

EIF4G2 (Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))

Origine

Souris

Source

  • 7
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    N-Term

    Fonction

    EIF4G2 Peptide - N-terminal region

    Séquence

    GQNAQKWIPA RSTRRDDNSA ANNSANEKER HDAIFRKVRG ILNKLTPEKF
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti- EIF4G2 Antibody (ARP90937_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    EIF4G2 (Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))

    Sujet

    Background Information: Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G, that contains the binding sites for eIF4A and eIF3, eIF4G in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. Transgene expression of the apolipoprotein B mRNA-editing enzyme (APOBEC-1) causes extensive editing of this mRNA, which could contribute to the potent oncogenesis induced by overexpression of APOBEC-1. In vitro and in vivo studies in human indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. This also appears to be true for mouse. Two alternatively spliced transcript variants that encode different isoforms have been found for this gene.

    Alternative Symbols: p97, Nat1, DAP-5, Natm1, E130105L11Rik

    Poids moléculaire

    99 kDa

    ID gène

    13690

    NCBI Accession

    NP_001035221

    UniProt

    Q62448
Vous êtes ici:
Chat with us!